MS-STAT Published: Simvastatin Benefits SPMS MS-STAT Published: Simvastatin Benefits SPMS
The drug was associated with a sizable reduction in brain atrophy and a small but significant slowing of disability in this phase 2 study of secondary progressive MS. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Disability | Health | Neurology | Neurosurgery | Simvastatin | Statin Therapy | Study | Zocor